Gossamer Bio Inc (GOSS)

R&D Expenses

$26.41M

Quarterly · Period ending: · USD

GOSS logo

GOSS R&D Expenses

Latest reported$26.41M
GOSS Quarterly R&D Expenses ($2.00K → $26.41M)
High-resolution chart · PNG

GOSS r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gossamer Bio Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
26,412,000
43,070,000
48,935,000
53,018,000
41,575,000
38,041,000
36,112,000
34,897,000
35,086,000
32,392,000
29,970,000
31,200,000
36,309,000
37,795,000
41,508,000
44,509,000
42,580,000
42,322,000
40,932,000
43,190,000
44,318,000
41,827,000
38,910,000
41,846,000
38,684,000
41,414,000
42,596,000
40,148,000
35,676,000
24,983,000
25,872,000
18,857,000
7,930,000
2,624,000
675,000
212,000
2,000
2,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.